Fibroblast growth factor-23 is associated with imaging markers of diabetic cardiomyopathy and anti-diabetic therapeutics

BACKGROUND: The biomarker fibroblast growth factor-23 (FGF-23) has been associated with increased cardiovascular morbidity and mortality in both patients with and without type 2 diabetes. The aim of this study was to evaluate the relationship between FGF-23 and cardiac structure, function and perfus...

Descripción completa

Detalles Bibliográficos
Autores principales: Sørensen, Martin H., Bojer, Annemie S., Jørgensen, Niklas R., Broadbent, David A., Plein, Sven, Madsen, Per L., Gæde, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528463/
https://www.ncbi.nlm.nih.gov/pubmed/32998751
http://dx.doi.org/10.1186/s12933-020-01135-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528463/
https://www.ncbi.nlm.nih.gov/pubmed/32998751
http://dx.doi.org/10.1186/s12933-020-01135-z

Ejemplares similares